CL's fundamentals are supported by global diversification, emerging-market growth and Hill's strengt

With the 10-year Treasury yield punishing rate-sensitive stocks, five consumer staples giants are qu

Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and low

A gas station attendant and part-time janitor from Vermont quietly accumulated over 95 stocks across

CL's innovation, premiumization and emerging-market expansion are strengthening its brands and creat

On a $3,000 combined investment, these Dividend Kings would pay $79 in income over the next year.

Investors looking for stocks in the Consumer Products - Staples sector might want to consider either

Colgate-Palmolive has sent dividend checks without interruption since Grover Cleveland's second term

The Federal Reserve may keep rates higher for longer, but these three dividend stocks are built arou

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Fluoride-free, anti-sensitivity toothpaste — formulated with naturally derived Calcium Carbonate and

Procter & Gamble and Colgate differ in portfolio breadth, category leadership, premiumization and di

Analysts raised targets for INSP, SECZ, CLF and WAT, while cutting targets for CRDO, CL and TTMI; ra

Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and

Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through e

NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today decla

Two Dividend Kings with 50-plus years of consecutive raises have reported earnings, and one of them

CL is betting on premium innovation, higher ad spending and targeted pricing to revive North America

Colgate is reportedly shopping Softsoap, Irish Spring, and Speed Stick with Goldman Sachs running th

Colgate-Palmolive is upgraded to a buy as organic growth momentum returns and profitability remains

Chasing the fattest yield on the screen is a trap most income investors fall into, but a handful of

Colgate-Palmolive is exploring a sale of certain mass-market personal care ‌brands, including Softso

RBC Capital analyst Nik Modi reiterates Colgate-Palmolive (NYSE:CL) with a Outperform and maintai

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price targ

TD Cowen analyst Robert Moskow maintains Colgate-Palmolive (NYSE:CL) with a Hold and raises the p

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and low

RBC Capital analyst Nik Modi maintains Colgate-Palmolive (NYSE:CL) with a Outperform and raises t

Evercore ISI Group analyst Robert Ottenstein maintains Colgate-Palmolive (NYSE:CL) with a Outperf

Colgate-Palmolive beats Q2 2026 earnings estimates, but North America weakness and tariff headwinds

Colgate-Palmolive (NYSE:CL) affirms FY2026 sales outlook from $20.790 billion-$21.605 billion to $20

Colgate-Palmolive (NYSE:CL) reported quarterly earnings of $0.99 per share which beat the analyst co

Improvement in market sentiment according to CNN Money Fear and Greed index. Dow Jones gains 600+ po

U.S. stock futures higher, focus on Chevron, Apple, ExxonMobil, Amazon and Colgate-Palmolive earning

Colgate-Palmolive Company (NYSE: CL) to release Q2 earnings on July 31, with analysts predicting EPS

Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and r

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and rai

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price targ

Citigroup analyst Filippo Falorni maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the

Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and

Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and rai

Bernstein analyst Cristian Rios initiates coverage on Colgate-Palmolive (NYSE:CL) with a Market P

Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and r

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and rai

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price targ

RBC Capital analyst Nik Modi reiterates Colgate-Palmolive (NYSE:CL) with a Outperform and maintai

Colgate warns Middle East conflict is driving up costs and hitting global spending. Get the full bre

Colgate-Palmolive (NYSE:CL) affirms FY2026 sales outlook from $20.790 billion-$21.605 billion to $20

Colgate-Palmolive (NYSE:CL) reported quarterly earnings of $0.97 per share which beat the analyst co